RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy

Status Recruiting

Clinical Trial Summary

This is a prospective multicentric Italian study to evaluate the arrhythmic risk in myotonic dystrophy type 1.

Clinical Trial Description

Myotonic dystrophy type 1 (DM1, Steinert disease) is a multisystem disorder that affects, beside muscle, several other organs, including the heart.

Cardiac involvement represents a major problem in the clinical management of patients, so that cardiac complications represent one of the primary causes of premature death in DM1. In particular there is a high incidence of sudden death, ranging from 2 to 30% of cases, so far principally related to the development of conduction blocks. However, literature reports of sudden death in patients implanted with pacemakers, as well as of spontaneous ventricular tachycardia would suggest a potential etiologic role also for ventricular arrhythmias. The lack of clinical research studies conducted on a large number of patients does not make available definite data regarding the etiology and the epidemiology of arrhythmic events in DM1. For the same reasons, other considerable topics, such as prognostic stratification of the arrhythmic risk and clinical management of life-threatening arrhythmias in DM1 patients, are still undefined.

To clarify these issues, the investigators propose a clinical research study performed on a large cohort of DM1 patients enrolled through a multicenter collaboration that also involves 5 cardiological-neurological Italian centres.

Aims of this study are:

- To estimate the incidence of arrhythmias and to characterize the brady-tachyarrhythmic mechanisms underlying the occurrence of cardiac sudden death in DM1;

- To verify by statistical analysis the reliability of data obtained from both non invasive and invasive diagnostic procedures as indexes useful for estimating the arrhythmic risk in DM1;

- To identify more adequate therapeutic guidelines in order to prevent the occurrence of life-threatening arrhythmias.

The protocol of study includes:

1. Clinical-genetic evaluation;

2. Non invasive and invasive diagnostic cardiac procedures;

3. The use of devices for diagnostic and therapeutic follow-up. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00127582
Study type	Interventional
Source	Catholic University of the Sacred Heart
Contact	Fulvio Bellocci, MD
Phone	+390630154187
Email	adellorusso@tin.it
Status	Recruiting
Phase	Phase 3
Start date	January 2003

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02923726` - Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP	N/A
Recruiting	`NCT05175937` - REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology
Completed	`NCT02026102` - A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)	N/A
Completed	`NCT01262508` - Development of Algorithms to Predict Hemodynamic Instability	N/A
Completed	`NCT00998218` - Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction	Phase 3
Completed	`NCT00845286` - Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial	N/A
Active, not recruiting	`NCT00562757` - Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias	N/A
Completed	`NCT00622453` - Arrhythmias in Myotonic Muscular Dystrophy	N/A
Completed	`NCT03833843` - Sudden Cardiac Death in Systemic Right Ventricle
Completed	`NCT04024865` - Domperidone and Risk of Serious Cardiac Events in Postpartum Women
Recruiting	`NCT05799833` - Low QRS Voltages in Young Healthy Individuals and Athletes
Recruiting	`NCT05694572` - Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices
Not yet recruiting	`NCT03622307` - Subcutaneous ICD Therapy Combined With VT Ablation for the Secondary Prevention of Sudden Cardiac Death	N/A
Recruiting	`NCT02056509` - The Effect of Chest Compression and Ventilation Coordination During Cardiopulmonary Resuscitation.	N/A
Recruiting	`NCT02058771` - Utilising Lifemap to Investigate Malignant Arrhythmia Therapy
Terminated	`NCT01948206` - Study of Paced QRS Duration as a Marker of Sudden Cardiac Death	N/A
Completed	`NCT01227785` - Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study	N/A
Completed	`NCT00534300` - Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker	Phase 1/Phase 2
Terminated	`NCT00524862` - Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death	N/A
Recruiting	`NCT00181233` - Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk